Who Discovered The Effects Of Malegra DXT Plus On Erectile Dysfunction?
Malegra DXT Plus is a combination drug primarily used to treat erectile dysfunction (ED) and premature ejaculation (PE). It contains two active ingredients: Sildenafil Citrate and Dapoxetine. While the specific combination as Malegra DXT Plus is a product developed by pharmaceutical companies (notably Sunrise Remedies), the discovery of the effects of its individual components on ED comes from earlier clinical research.
The effects of Sildenafil Citrate on erectile dysfunction were discovered by scientists working at Pfizer in the late 1980s and early 1990s. Originally studied as a treatment for angina, Sildenafil was found to cause improved erections as a side effect. This led to its development and approval as the first oral medication for ED, marketed as Viagra in 1998. The groundbreaking discovery was led by researchers including Dr. Nicholas Terrett and Dr. Peter Dunn.
Dapoxetine, on the other hand, was developed as a short-acting selective serotonin reuptake inhibitor (SSRI) to treat premature ejaculation. Its effects were identified in clinical trials during the early 2000s.
Malegra DXT Plus combines these two ingredients to address both ED and PE simultaneously. While the product itself is a formulation by pharmaceutical manufacturers, the foundational discoveries behind its effectiveness trace back to the separate development of Sildenafil and Dapoxetine by medical researchers over the past few decades.  |